ADVERTISEMENT
SARS-CoV-2-Reactive T Cells Found in Patients with Severe COVID-19
SARS-CoV-2-Reactive T Cells Found in Patients with Severe COVID-19
A small subset of uninfected people also had SARS-CoV-2-fighting T cells, a finding that scientists are still trying to figure out.
SARS-CoV-2-Reactive T Cells Found in Patients with Severe COVID-19
SARS-CoV-2-Reactive T Cells Found in Patients with Severe COVID-19

A small subset of uninfected people also had SARS-CoV-2-fighting T cells, a finding that scientists are still trying to figure out.

A small subset of uninfected people also had SARS-CoV-2-fighting T cells, a finding that scientists are still trying to figure out.

T cells

an image of a molecule with three intertwined components
SARS-CoV-2–Fighting T Cells Found in Recovered Patients
Shawna Williams | May 15, 2020 | 2 min read
While the finding doesn’t prove people become immune to the virus after infection, it is good news for vaccine development.
Natural Killer Cell Therapies Catch Up to CAR T
Bianca Nogrady | Apr 1, 2020 | 8 min read
There’s a new cell-based cancer immunotherapy on the block.
Immunology Leader Vincenzo Cerundolo Dies
Ashley Yeager | Jan 16, 2020 | 2 min read
The Oxford researcher’s work on lipid and peptide antigens revealed key mechanisms in inflammation, immunotherapy, and vaccination, which are being pursued in clinical trial treatments.
Keto Diet Protects Mice from Flu
Abby Olena, PhD | Nov 15, 2019 | 3 min read
The low-carb, high-fat diet increases the presence of gamma-delta T cells in the animals’ lungs, improving a mucus barrier against the virus.
inflammation in mice gut
Mouse Diets Affect How Gut Bacteria Interact with T Cells
Shawna Williams | Jun 1, 2019 | 2 min read
An experiment delves into how the microbiome shapes immunity.
a drop of blood for a newborn's heel is placed on a piece of paper
Gene Therapy Effective for Severe Combined Immunodeficiency
Shawna Williams | Apr 17, 2019 | 4 min read
Researchers report they’ve found a way to restore immune function in infants with one form of “bubble boy disease.”
 immunotherapy  treatment may cause latent infections of Mycobacterium tuberculosis to flare up in cancer patients
Tuberculosis Can Emerge After Cancer Immunotherapy
Ashley Yeager | Apr 1, 2019 | 4 min read
At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.
Salt Could Play a Role in Allergies
Abby Olena, PhD | Feb 20, 2019 | 3 min read
High salt concentrations are present in the affected skin of people with atopic dermatitis and promote the differentiation of the T helper cells involved in the development of allergic diseases.
Infographic: The Omentum’s Role in Health and Disease
Selene Meza-Perez and Troy D. Randall | Oct 1, 2018 | 1 min read
Belly fat helps fight infection, but is also a common site of metastasis.
Electric Shock Allows for CRISPR Gene Editing Without a Viral Vector
Ashley Yeager | Jul 12, 2018 | 2 min read
Brief electroporation appears to make T cells more receptive to new genetic material, which could speed the development of immunotherapies.
New Ovarian Cancer Vaccine Shows Promise
Catherine Offord | Apr 12, 2018 | 2 min read
A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
High-Throughput Epigenetics Analyses
Jyoti Madhusoodanan | Jan 1, 2018 | 7 min read
Emerging technologies help researchers draw mechanistic links between metabolism and epigenetic modification of DNA.
New CAR T-Cell Therapy Shows Promise in Trial for Leukemia
Katarina Zimmer | Nov 21, 2017 | 2 min read
The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 
First CAR T-Cell Therapy Approved in U.S.
Shawna Williams | Aug 30, 2017 | 1 min read
The genetically modified blood cells will be used for patients with a type of acute lymphoblastic leukemia, when other treatments fail.
Immunotherapy Promising for Diabetes: Study
Aggie Mika | Aug 9, 2017 | 2 min read
A small clinical trial demonstrates that peptide immunotherapy can halt the progression of early-stage type 1 diabetes.
The Ever-Expanding T-Cell World: A Primer
Ashley P. Taylor | Aug 7, 2017 | 8 min read
Researchers continue to identify new T-cell subtypes—and devise ways to use them to fight cancer. The Scientist attempts to catalog them all.
T Cells That Drive Toxic Shock in Mice Identified
Ashley Yeager | Jun 20, 2017 | 3 min read
Overzealous activity by mucosa-associated invariant T (MAIT) cells in response to bacterial toxins can lead to illness instead of stopping it.
Gene Mutations Foretell Immunotherapy Response
Aggie Mika | Jun 12, 2017 | 2 min read
A drug that blocks an immune checkpoint protein effectively treats tumors in patients with deficient DNA repair genes. 
Pinpointing the Culprit
Rachel Berkowitz | Jun 1, 2017 | 8 min read
Identifying immune cell subsets with CyTOF
ADVERTISEMENT